Faculty News
Prof. Aswath Damodaran's research on financial statements is referenced
—
Excerpt from American Progress Action Fund -- "According to financial statement research by New York University professor Aswath Damodaran, drug and biotechnology firms paid a small fraction of the statutory rate (effective rates of 4.5 and 5.6 percent, respectively); while heavy construction and trucking firms paid close to 35 percent (33.8 percent and 30.9 percent, respectively)."